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Objective:Mentalization is the capacity to understand behavior as the expression of various mental states and is assumed to be important in a
range of psychopathologies, especially personality disorders (PDs). The first aim of the present study was to investigate the relationship
between mentalization capacity, operationalized as reflective functioning (RF), and clinical manifestations before entering study treatment.
The second aim was to investigate the relationship between baseline RF and long-term clinical outcome both independent of treatment
(predictor analyses) and dependent on treatment (moderator analyses).
Methods: Seventy-nine patients from a randomized clinical trial (Ullevål Personality Project) who had borderline and/or avoidant PD were
randomly assigned to either a step-down treatment program, comprising short-term day-hospital treatment followed by outpatient combined
group and individual psychotherapy, or to outpatient individual psychotherapy. Patients were evaluated on variables including symptomatic
distress, psychosocial functioning, personality functioning, and self-esteem at baseline, 8 and 18 months, and 3 and 6 years.
Results: RF was significantly associated with a wide range of variables at baseline. In longitudinal analyses RF was not found to be a
predictor of long-term clinical outcome. However, when considering treatment type, there were significant moderator effects of RF. Patients
with low RF had better outcomes in outpatient individual therapy compared to the step-down program. In contrast, patients in the medium RF
group achieved better results in the step-down program.
Conclusion: These findings indicate that RF is associated with core aspects of personality pathology and capture clinically relevant phenomena in
adult patients with PDs. Moreover, patients with different capacities for mentalization may need different kinds of therapeutic approaches.
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Deficits in mentalizing capacities are believed to play an
important role in a range of psychopathologies [1].Mentalization
is defined as the capacity to understand and interpret—implicitly
and explicitly – one’s own behaviors and those of others as
expressions of mental states such as feelings, fantasies, beliefs,
and desires [2]. The concept refers to complex bio-psycho-social
phenomena that are not easily measured [3]. Over the last two
decades, the mentalization construct has been operationalized as
reflective functioning (RF)with a scoringmanual for application
to the Adult Attachment Interviews (AAI) [4,5], assessing
mentalizing ability based on the individual’s narratives of his/her
childhood attachment experiences. This method measures
mentalizing related to attachment relationships and expressesess article under the CC BY-NC-ND license (http://creativecommons.org/
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satisfactory construct validity and psychometric properties of
the RF scale applied to AAI [6], and the measure is currently
seen as the gold standard for measuring RF.
Several studies applying different methodologies have
investigated whether low levels of RF are related to
psychiatric disorders like substance abuse [7,8], depression
[9–11], anxiety disorders [12], eating disorders [13,14], and
psychosis [15]. The findings from these studies are
inconsistent regarding whether RF in such samples deviates
from RF levels believed to characterize the normal population.
A recent review of the RF literature concludes that the evidence
for the association between RF and severity of symptoms for
different psychiatric disorders is inconclusive [16].
Mentalizing deficits have been proposed to represent a core
mechanism in personality disorders (PDs), particularly
borderline PD (BPD). Mentalization capacity is assumed to
buffer against psychopathology in individuals exposed to
trauma and abuse and to relate to more adaptive affect
regulation and interpersonal functioning [17–20]. A few
empirical studies have found low levels of RF in samples of
BPD. In a study of Fonagy and colleagues [14] patients with
BPD had low RF compared with a non-clinical control group,
as well as compared with other PDs. The relationship between
low RF and BPD, however, was mainly apparent in the
presence of childhood abuse, supporting RF as a protective
factor. RF levels close to those of the BPD population in
Fonalgy et al’s study [14] have also been reported in BPD
patients in two separate treatment studies [21,22]. However,
there have been divergent findings regarding mentalizing
abilities in subject with BPD, depending on experimental
context. Whereas some studies, applying other methods to
assess mentalizing, provide evidence that BPD displays
inferior mentalizng capacity, other studies show that subjects
with BPD in fact exhibit a superior ability to mentalize [23].
Moreover, a recent report described BPD patients as not
differing from those with other PDs; both groups had low RF
compared to non-psychiatric controls [19]. Thus, mentaliza-
tion deficits may extend to PDs other than BPD. Mentaliza-
tion is a multifaceted concept [3], and different types of PD
could be associated with specific mentalizing problems.
Although more research is required, it is hypothesized that
subjects with BPD have particular mentalizing difficulties in
the context of attachment relationships and high emotional
arousal [18] whereas subjects with cluster C PDs like
avoidant PD (AvPD) may have poor access to own and
others states of mind on a more general basis, in part related
to poor awareness and tolerance of affects [24–26].
Despite increasing interest in RF as a theoretically and
clinically meaningful aspect of PD, few studies have investi-
gated how RF is associated with clinical manifestations of PD
psychopathology in terms of symptomdistress and psychosocial
or personality functioning. An association among hypermenta-
lizing (i.e., excessive but inaccurate mentalization), as assessed
by theMovie for the Assessment of Social Cognition [27], BPD
traits, and self-reported difficulties in emotion regulation wasfound in an inpatient adolescent sample [28]. Chiesa et al. [19]
found that RF was negatively correlated with self-reported
symptom distress in their mixed PD and non-psychiatric
sample. No study has so far investigated RF and everyday
psychosocial function in clinical PD samples; however, in a
population of unemployed, low-income, and disadvantaged
adults in NewYorkwho participated in a job-readiness training
program, those with higher RFmore seldom had PDs and were
more likely to complete the program and attain a job [29].
Two studies that examined associations between RF and
severity of psychopathology in terms of the number of Axis I
andAxis II disorders reported inconsistent results. The first, by
Bouchard and colleagues [30], included subjects from both
clinical and non-clinical populations and indicated that RFwas
negatively correlated with the number of Axis I and Axis II
disorders. Such correlations were not confirmed in the more
recent treatment study of Fisher-Kern et al. [22]. On the other
hand, Fisher-Kern et al. [22] reported among their BPD
patients an association between RF and level of personality
organization, as assessed by the Structured Interview of
Personality Organization (STIPO [31]). STIPO is based on
Kernberg’s psychodynamic conceptualization of differentia-
tion and integration of internal representations of self and
others, and covers several domains that are central to
personality functioning such as identity consolidation and
quality of object relations [32,33]. Thus, our knowledge of how
RF may relate to mental distress, extent of psychopathology as
well as degree of maladaptive personality functioning is still
scarce. Clearly, more studies are needed to evaluate the clinical
implication of mentalization deficits.
Psychosocial treatment, including psychotherapy, is consid-
ered the main treatment approach for patients with PDs [34,35],
yet there seems to be substantial variation within this patient
group regarding the degree of benefit gained from psychother-
apy [36]. Information on factors predicting the outcome of
therapy could facilitate identification of those at risk for poor
outcome and enable identification of helpful therapy processes
[37]. Studies of psychologicalmindedness and alexithymia tend
to show that patients with poor abilities to understand the
psychological meaning underlying emotional experiences and
behaviors in self and others may have a less favorable outcome
[38,39]. Given that RF, psychological mindedness and
alexithymia are closely related through processes concerning
recognition and thinking about one’s own or other’s internal
states [25], such results point towardsRF as a potential predictor
of clinical course. Yet, although therapies addressing mentaliz-
ing deficits seem to reduce self-harm, general symptoms,
interpersonal distress, and personality pathology in patientswith
BPD [21,40–43], few studies have examinedwhether mentaliz-
ing capacities at the onset of treatment predict clinical outcome
in patients with PDs. The results from two treatment studies that
included patients with eating disorders [44] or depression [10]
were inconsistent as regards the predictive value of RF for
outcome of three months of inpatient treatment and long-term
psychoanalytic treatment, respectively. Thus, the general
predictive value of RF remains uncertain.
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treatment outcome varies according to treatment type and
format. Some treatment approaches may be more challenging
for patients with poor mindreading abilities. As an example,
patient’s mentalizing deficits could influence their capacity to
engage in group psychotherapy focusing on exploration and
interpretation of internal states and interpersonal dialogues, and
consequently affect therapeutic benefits. Whereas a predictor
influences outcome regardless of treatment characteristics, a
moderator differentially influences outcome depending on the
type of treatment. Given the variety of PD treatment options, an
important question is howmentalizing capacities may moderate
outcomes under different treatment conditions.
The Ullevål Personality Project (UPP) is a randomized
clinical trial designed to compare outcomes of two of the most
common treatment modalities for PD patients in Europe and
Norway at that time: (1) a step-down program, which in this
project comprised short-term day-hospital treatment followed by
a combination of long-term group and individual psychotherapy
for a maximum of 4 years, and (2) outpatient individual
psychotherapy. The patients were evaluated on a wide range of
outcomevariables at baseline and later followup investigations at
8 months, 18 months, and 3 and 6 years after the initial random
assignment. The analyses at the 6-year follow-up showed no
difference in outcome between treatment conditions in the total
mixed PD sample, although the clinical course did differ between
treatments [45]. In the previous 3-year follow-up investigation,
differentiating between patients with low and medium pretreat-
ment RF levels yielded significant results [46]. Patients with low
RF had greater improvements in psychosocial functioning in the
outpatient condition than in the step-down condition. For patients
with medium/high RF, 3-year outcomes did not differ by
treatment condition. So far, this study is the only one to report a
moderator effect of RF on clinical outcomes of psychotherapeu-
tic treatment. The value of such findings is considerably
strengthened if these effects can be demonstrated to be long term.
The aim of the present study was twofold. The first aim
was to investigate the relationship between mentalization
capacity operationalized as RF and clinical manifestations
before entering study treatment. The second aim was to
investigate the relationship between baseline levels of RF
and long-term outcomes. More specifically, we addressed
three research questions: (1) What were the associations
between RF and psychosocial functioning, symptom dis-
tress, interpersonal problems, self-esteem, and personality
functioning at baseline? (2) Did baseline levels of RF predict
clinical outcome at 6 years of follow-up? (3) Were baseline
levels of RF a moderator of long-term treatment effects, and
if so, what were the magnitudes of these clinical differences?2. Methods
2.1. Setting and design
The UPP was conducted at the Department of Personality
Psychiatry (DPP) at Oslo University Hospital. The StateHealth Insurance Fund covered the expenses for both
treatment conditions. Patients were evaluated before treat-
ment, and after 8 months, 18 months, 3 years, and 6 years.
All patients received optional psychopharmacological con-
sultations with a psychiatrist as part of the follow-up
evaluations. The staff at the DPP conducted the initial
clinical and diagnostic evaluations while PhD students and
research assistants performed the follow-up interviews and
diagnostic evaluations. Written informed consent was
obtained from participants after they were provided with a
description of the study. The Data Inspectorate and Regional
Ethics Committee in Norway approved the project. Study
design and recruitment of therapists have been described in
more detail in previous publications [47].
2.2. Participants
The UPP comprised a total of 113 patients. Only patients
with PDs were included in the trial, and exclusion criteria
were schizotypal PD, antisocial PD, ongoing alcohol or drug
dependence, psychotic disorders, bipolar I disorder, untreat-
ed ADHD (adult type), pervasive developmental disorder
(e.g., Asperger’s syndrome), organic syndromes, and
homelessness. RF was measured only in a subsample of
patients with a diagnosis of BPD and/or AvPD, comprising
79 patients in total. A total of 29 patients had a diagnosis of
AvPD but not BPD, 16 patients had diagnoses of both AvPD
and BPD, and 34 patients had a diagnosis of BPD and not
AvPD. The average age at the time of inclusion was
30.6 years, and 81% of participants were female. Fifty
percent of the participants had more than 12 years of
education, and 41% had not worked or studied during the last
year. Among those who had worked or studied in the last
year, the average number of months doing so was 7.7. A total
of 83% of the patients were diagnosed with a mood disorder
at baseline; 85% had an anxiety disorder, and 33% had a
substance disorder. After the randomization procedure,
which left patients in one of the two treatment conditions,
the two conditions did not differ significantly in socio-
demographic or clinical variables [46]. In the 3-year
follow-up study, one patient with an RF score was not
included in the analyses because of an administrative failure.
This patient was, however, included in later studies, the
6-year follow-up investigation, and the present study. The
differences in patient numbers did not alter the results of the
comparison of treatment conditions at baseline.
2.3. Completeness of data
Fig. 1 depicts the flow of patients throughout the study.
Of the 79 patients, 55 (69%) patients attended the 6-year
follow-up, which constituted 71% of the original patients in
the step-down group and 68% of the original participants in
the outpatient group. The difference in attendance rates
between the two treatment conditions was not statistically
significant. Compared to patients who participated in the
6-year follow-up investigation, those who did not attend had
Fig. 1. Patient flow in a randomized clinical trial comparing a step-down treatment program with outpatient treatment.
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(SD = .56) versus 1.70 (SD = .63), p = .01] and more often
had an eating disorder (24% versus 7%, p = .04). There were
no other statistically significant clinical, diagnostic, or
sociodemographic variables differentiating patients who
did and did not attend the 6-year follow-up. The response
rates for the other follow-up investigations were 91% at
8 months, 76% at 18 months, and 73% at 3 years.2.4. Treatments
2.4.1. Step-down day hospital treatment (step-down treatment)
The step-down treatment condition started with an
18-week day-hospital treatment phase that included a
combination of psychodynamic and cognitive–behavioral
group therapies for 3 to 4 days per week. The written
treatment guidelines adhered to relational psychotherapy,
with references to psychodynamic group psychotherapy,
self-psychology, and mentalization-based thinking. After
this initial day-hospital treatment phase, the patients
continued with outpatient combined psychotherapy, which
included a combination of weekly 1.5-hour group therapy
sessions (maximum of 4 years) and weekly individual
therapy (maximum of 2.5 years). Group therapists were
regular staff from the DPP (three psychiatric nurses, two
psychiatrists, one residential doctor who specialized in
psychiatry, one specialist in clinical psychology, one art
therapist, one social worker, and one physiotherapist). Seven
of the ten therapists had 5 years of training in group analysis.
The mean age of the therapists was 48 years (SD = 9), and80% were women. The individual therapists involved in the
follow-up outpatient treatment comprised 16 psychologists,
12 psychiatrists, and two psychiatric nurses (n = 30). Seven
were recruited from the regular staff at the DPP, the rest was
mainly therapists in private practice. The therapists treated
between one and three patients each. The mean age of the
individual therapists was 50 years (SD = 9), and 57% were
women. The mean work experience as psychotherapists was
16 years (SD = 8).
The average treatment duration for patients in the step-down
treatment was 32 months (SD = 16), and the median was
30 months (range: 7–58). The average number of therapy
sessions (including both individual and group) during the
outpatient follow-up therapy was 107 (SD = 76), and the
median was 108 (range: 1–290). Themean interval between the
end of study therapy and the 6-year follow-up investigation
(post-treatment phase) was 38 months (SD = 17), and the
median was 40 months (range: 8–68).
2.4.2. Outpatient individual psychotherapy (outpatient treatment)
The outpatient treatment was mainly conducted by
therapists in private practice. The therapists were instructed
to treat the patients according to their own preferred method
and practice. The researchers gave no instructions to the
therapists regarding the duration and intensity of psycho-
therapy, nor did they interfere with any treatment decisions.
Thirty-two external therapists were recruited as outpatient
individual therapists (16 psychologists, 15 psychiatrists, and
one resident). Each treated one to three patients. The mean
age of the therapists was 55 years (SD = 8), and 41% were
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20 years (SD = 8).
The average treatment duration was 25 months (SD = 20),
the median was 20 months (range: 1–72), and the average
number of therapy sessions was 65 (SD = 60) with a median of
45 (range: 2–283). The mean interval between the end of study
therapy and the 6-year follow-up investigation (post-treatment
phase) was 46 months (SD = 19), with a median of 52 months
(range: 0–72).2.5. Assessments
2.5.1. AAI and RF
The AAI [48] was scored with the RF scale [5] to measure
each participant’s capacity for mentalization. In the AAI
interview, participants were asked to describe their child-
hood attachment relationships and everyday routines (e.g.,
going-to-bed routines). They were also asked more specific
questions about traumas and experiences of rejection,
separation, and loss. Furthermore, the subjects were invited
to reflect upon their caregivers’ mental states and intentions
(e.g., why they thought their parents behaved as they did
during their childhood), and how they thought their
childhood experiences with their parents affected their
adult personalities. The RF scale evaluates people’s capacity
to think and reflect upon their own and others’mental states and
the level of complexity of this reflection. The scale ranges from
−1 (negative RF: a systematic resistance to the reflective stance)
to 9 (exceptional RF: i.e., fresh, complex, and unusually
sophisticated reflections with original elaborations).
AverageRF values in the current samplewere 3.0 (SD = 1.5)
in the step-down treatment and 3.5 (SD = 1.7) in the outpatient
treatment condition. The average intraclass correlation coeffi-
cient (ICC 2.1) for the overall RF scores was .73, after exclusion
of one outlier, and .61 when this outlier was included [46]. The
outlier was a patient who initially received an RF score of 5 and
then of 0 in the reliability test. The two raters disagreed about the
level of authenticity of the patient’s capacity for mentalization.
Although one of the two raters experienced the patient as
genuinely mentalizing, the other rated the patient’s mentalizing
efforts as self-distorted and generally poorly integrated. Because
of the intention-to-treat approach in this study, all patients were
included in the statistical analyses.
In the present study, RF scores were dichotomized; RF
scores below 3 were categorized as low (n = 26), and scores
of 3 and above were categorized as medium (n = 52). The
term ‘medium RF’ is used instead of high RF because high
values in this patient group are believed to be relatively low
compared to non-clinical samples. This dichotomization was
based on an a priori decision. The rationale is both empirical
[14] and based on the clinical impression of a clear difference
between patients with almost no capacity for mentalization
(i.e., below RF 3) and patients with mentalizing tendencies
(i.e., RF 3 and above).
The ratings in this study were based on a thorough
reading of verbatim transcripts made from audiotapes ofAAIs by three different coders (all authors of the present
study; MJ, FR and TW). The coders had attended the course
“Reflective Functioning on the Adult Attachment Interview”
at the Anna Freud Centre in London, and they successfully
completed the Reliability Test related to this course. All three
were authorized to utilize the Reflective Functioning Scale
for clinical and research purposes and publish research data
obtained with the scale.
2.5.2. Axis I and II diagnoses
Axis I diagnoses were based on the Mini International
Neuropsychiatric Interview (known as the MINI) [49]. Axis
II diagnoses were determined with the Structured Clinical
Interview for DSM-IV (SCID-II) [50]. Two independent
raters scored 24 videotaped SCID-II baseline interviews. The
kappa value for three PDs represented by at least five cases
was .75 for avoidant PD, .66 for borderline PD, and .71 for
paranoid PD; these values indicated acceptable diagnostic
reliability. The reliability (ICC 2.1) for total number of
SCID-II criteria was .83.
2.5.3. Symptom distress
Self-reported symptom distress was measured with The
Symptom Checklist (SCL-90-R) [51], which comprised 90
questions, each rated on a scale from 0 (not at all) to 4 (very
much). The SCL-90-R was designed to cover the major
symptoms of psychiatric distress. The scores were summa-
rized with the GSI, which is the mean score of the 90 items.
2.5.4. Interpersonal problems
Self-reported interpersonal problems were measured with
the Circumplex of Interpersonal Problems (CIP) [52]. The
CIP is a 48-item Norwegian version of the Inventory of
Interpersonal Problems-Circumplex version [53]. The CIP
has a 5-point Likert response format that ranges from 0 (no
distress) to 4 (extremely distressing). The sum score of the
two versions correlates .99.
2.5.5. Psychosocial functioning
Psychosocial functioning was assessed with the Global
Assessment of Functioning (GAF). The GAF is rated on a
scale from 0 to 100, and a high score indicates a high level of
functioning. The GAF scores were observer rated according
to a split symptom and function version [54], and only the
lower of the two scores was used in the analyses. The
reliability (ICC 2.1) of the GAF scores in the whole sample
was .56 at baseline, .81 at 8 months, .85 at 18 months, .94 at
3 years, and .92 at 6 years. The Work and Social Adjustment
Scale (WSAS) is a self-reported 5-item scale of functional
impairment that measures level of impairment on a scale
from 0 to 8, where 0 indicates no impairment at all and 8
indicates very severe impairment. The scores on the five
different items are totaled in a sum score (range: 0–40).
2.5.6. Self-esteem
Self-esteem was assessed using the Index of Self-esteem
(ISE) [55,56], a 25-item self-evaluative questionnaire that
measures the degree or severity of a subject's self-esteem
able 1
dependent t-test analyses between patients with low and medium RF at
aseline.
Low RF Medium RF
Mean (SD) Mean (SD) p
SI 2.08 (0.67) 1.7 (0.53) 0.012
IP 1.97 (0.43) 1.62 (0.5) 0.004
AF 46.3 (4.5) 47.2 (3.9) 0.383
SAS 27.74 (6.4) 24.27 (7.22) 0.041
E 65.11 (11.11) 56.76 (10.72) 0.002
IPP-118 domains
entity Integration 1.70 (0.52) 2.17 (0.61) 0.001
elational Capacities 2.10 (0.59) 2.46 (0.64) 0.018
elf-control 2.63 (0.56) 2.64 (0.70) 0.955
SI = Global Severity Index, CIP = Circumplex of interpersonal problems,
AF = Global Assessment of Functioning, WSAS = Work and Social
djustment Scale, ISE = Self-esteem.
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100, where a score of 0 indicates that the subject has none of
the attributes and 100 represents the highest possible distress
level. Respondents who score above 30 are assumed to have
clinically significant self-esteem problems.
2.5.7. Personality functioning
(Mal)Adaptive personality functioning were measured
using the 60-item short form of Severity Indices of
Personality Problems (SIPP-118) questionnaire. The 60
items are directly assigned to five higher-order domains:
Self-control, Identity Integration, Relational Capacities,
Responsibility, and Social Concordance. Scores range from
1 to 4, with lower scores reflecting more maladaptive levels
of personality functioning [57]. In the current study, only
three out of the five domains were used: Self-control,
Identity Integration, and Relational Capacity. The rationale
for using only three domains was multiple. First, to reduce
the total number of analyses, next, these three domains were
regarded most clinically relevant, and lastly they have also
shown the best construct validity in the full version of
SIPP-118 (Verheul 2008).
2.6. Statistical analysis
All results were analyzed using an intention-to-treat
approach based on treatment assignments. The baseline
association between RF and clinical variables was assessed
using an independent t-test (two-tailed). Linear mixed
modeling (LMM) was used for all longitudinal analyses
with maximum likelihood as the method of estimation. The
parameters of interest were time × RF (predictor analyses)
and time × RF × treatment (moderator analyses). Separate
random intercepts and slopes were included when proven to
enhance the model fit. Time was used as a linear interaction
for all LMM analysis. Missing at random (MAR) was
assumed when assessing the magnitude of selection bias
from loss to follow-up. Although it is not possible to test the
MAR assumption, a comparison with complete cases
(participants with all follow-up assessments) is informative
and was conducted in this study. Within-group pre-post
effect sizes were computed using Cohen’s d, with pooled
pre- and post-SD adjustment for sample size. When
interpreting the significance levels, it is important to keep
in mind that no correction for multiple testing was conducted
in this trial. All analyses were performed using SPSS
(version 20; SPSS Inc.).3. Results
3.1. Associations between RF and clinical variables at baseline
Table 1 shows the differences between patients with low and
medium RF at baseline. Patients in the low RF group had
significantly higher levels of GSI, CIP, and WSAS at baseline
compared with the medium RF group. They also had
significantly lower ISE and lower levels of the personalityT
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Capacity. Patients with low and medium RF values did not
differ significantly in the variables GAF and Self-control.
Furthermore, at baseline, there were no differences
between patients with low and medium RF values in number
of PD criteria or Axis I diagnoses. Concerning the baseline
distribution of patients in the medium and low RF groups, for
patients with AvPD with or without co-occurring BPD, the
low RF group had a significantly larger proportion of patients
(p = .04). For patients with BPD, with or without AvPD,
however, there was a non-significant trend towards a larger
proportion of patients in the medium RF group (p = .086).
3.2. RF as a predictor of clinical outcome
LMM analyses of RF × time, indicating whether RF
predicted improvement across treatments over time, showed
no significant effects on any of the outcome variables (GSI, p =
.85; CIP, p = .93; GAF, p = .16;WSAS, p = .56; ISE, p = .80;
Identity Integration, p = .95; Relational Capacity, p = .99;
Self-control, p = .78). Adjustments were done for the potential
confounding effects from age and gender at baseline.
3.3. RF as a moderator of treatment effect
Tables 2 and 3 show the LMMestimates from the three-way
moderator analyses (time × treatment × RF) for the clinical
variables and personality functioning, respectively. RF was a
significant moderator of treatment effects for GSI, CIP, GAF,
Identity Integration, Relational Capacities, and Self-control but
not for the outcome variables ISE and WSAS. The direction of
the interaction effects of RF on treatment condition is shown as
effect sizes in Table 4 and as graphs in Fig. 2.
Patients in the medium RF group in the step-down
treatment had greater effect sizes on all outcome variables
when compared to patients with medium RF in the outpatient
treatment (Table 4). Average effect sizes for patients with
medium RF in the step-down treatment were 2.24 while
average effect sizes for patients with medium RF in the
outpatient treatment condition were 1.0. Between-treatment
Table 2
Reflective functioning (RF) as a moderator of treatment effects on clinical outcome.
Dependent variable and
parameter
Estimate df t p 95% Confidence interval
Lower bound Upper bound
GSI dependent variable
Intercept 1.78 88.28 8.91 0.000 1.38 2.17
Time −0.01 69.79 −2.83 0.006 −0.02 0.00
RF −0.32 87.15 −1.37 0.174 −0.79 0.15
Treatment 0.08 86.07 0.32 0.747 −0.43 0.60
Time × RF 0.01 66.09 1.43 0.156 0.00 0.01
Time × treatment 0.00 65.50 0.77 0.442 −0.01 0.01
RF × treatment 0.06 85.12 0.18 0.860 −0.57 0.68
Time × treatment × RF −0.01 62.67 −2.26 0.027 −0.02 0.00
CIP dependent variable
Intercept 1.75 79.42 11.67 0.000 1.45 2.05
Time −0.01 69.40 −3.24 0.002 −0.02 0.00
RF 0.22 78.68 1.13 0.261 −0.17 0.61
Treatment −0.21 79.02 −1.17 0.246 −0.56 0.15
Time × RF 0.01 65.83 1.48 0.144 0.00 0.01
Time × treatment 0.01 65.88 1.73 0.088 0.00 0.01
RF × treatment −0.14 78.31 −0.60 0.550 −0.61 0.33
Time × treatment × RF −0.01 63.23 −2.27 0.027 −0.02 0.00
GAF dependent variable
Intercept 46.5 70.62 36.71 0.000 43.9 49.0
Time 0.32 44.47 4.37 0.000 0.17 0.47
RF −0.36 70.73 −0.22 0.828 −3.69 2.96
Treatment 1.20 70.69 0.79 0.430 −1.81 4.21
Time × RF −0.20 39.97 −2.09 0.043 −0.39 −0.01
Time × treatment −0.07 42.36 −0.80 0.428 −0.24 0.10
RF × treatment −0.01 70.80 0.00 0.996 −4.05 4.03
Time × treatment × RF 0.26 39.25 2.27 0.029 0.03 0.48
WSAS dependent variable
Intercept 23.7 70.94 9.86 0.000 18.9 28.4
Time −0.12 63.67 −1.84 0.071 −0.24 0.01
RF 2.59 70.36 0.83 0.410 −3.64 8.83
Treatment −3.12 70.72 −1.10 0.276 −8.80 2.55
Time × RF 0.01 59.02 0.14 0.889 −0.15 0.17
Time × treatment 0.01 58.96 0.11 0.912 −0.14 0.15
RF × treatment −0.69 70.44 −0.18 0.856 −8.25 6.87
Time × treatment × RF −0.07 55.75 −0.73 0.471 −0.26 0.12
ISE dependent variable
Intercept 58.4 72.13 15.73 0.000 51.0 65.8
Time −0.16 62.30 −2.17 0.034 −0.32 −0.01
RF 8.67 71.64 1.79 0.078 −1.00 18.35
Treatment −3.93 72.19 −0.89 0.376 −12.72 4.86
Time × RF 0.04 58.73 0.37 0.709 −0.15 0.23
Time × treatment 0.05 58.81 0.60 0.551 −0.12 0.23
RF × treatment −9.33 71.78 −1.58 0.118 −21.06 2.41
Time × treatment x RF −0.12 56.18 −1.10 0.277 −0.35 0.10
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variables showed medium to high effect sizes in favor of the
step-down treatment condition.
In contrast, patients with low RF in the outpatient treatment
had greater effect sizes than patients with low RF in the
step-down treatment condition on all outcome variables except
self-esteem. The average effect size for patients with a low RF
was 1.81 in the outpatient treatment and 1.22 in the step-down
treatment condition. Between-treatment comparison of LMM
estimated values after 6 years showed medium to high effectsizes in favor of the outpatient treatment (except for self-esteem)
for patients with low RF at baseline.
3.4. Attrition bias
All results showing statistically significant moderator effects
of RF in the intention-to-treat analyses also showed a p value
close to the alpha level of .05 in the complete case analyses: GSI,
p = .06; CIP, p = .09; GAF, p = .06; SIPP-118; Identity
Integration, p = .08; Relational Capacity, p = .05; Self-control,
Table 3
Reflective functioning (RF) as a moderator of treatment effects on personality functioning.
Dependent variable and
parameter
Estimate df t p 95% Confidence interval
Lower bound Upper bound
Self-control dependent variable
Intercept 2.59 84.99 23.64 0.000 2.37 2.80
Time 0.01 54.82 7.22 0.000 0.01 0.01
RF −0.08 85.92 −0.42 0.674 −0.44 0.29
Treatment 0.01 86.73 0.08 0.933 −0.30 0.33
Time × RF −0.01 56.12 −2.26 0.028 −0.01 0.00
Time × treatment −0.01 55.23 −3.44 0.001 −0.01 0.00
RF × treatment 0.08 88.90 0.28 0.781 −0.48 0.63
Time × treatment × RF 0.01 61.40 2.77 0.007 0.00 0.02
Identity dependent variable
Intercept 2.35 77.67 20.02 0.000 2.11 2.58
Time 0.02 52.68 7.03 0.000 0.01 0.02
RF −0.51 77.19 −2.59 0.011 −0.90 −0.12
Treatment −0.02 78.21 −0.14 0.892 −0.36 0.31
Time × RF −0.01 53.33 −1.58 0.120 −0.01 0.00
Time × treatment −0.01 51.74 −2.66 0.011 −0.01 0.00
RF × treatment 0.17 78.12 0.58 0.567 −0.42 0.76
Time × treatment × RF 0.01 56.56 2.08 0.042 0.00 0.02
Relation dependent variable
Intercept 2.63 89.56 21.90 0.000 2.39 2.87
Time 0.01 90.70 6.05 0.000 0.01 0.01
RF −0.48 90.10 −2.39 0.019 −0.88 −0.08
Treatment −0.01 90.72 −0.08 0.934 −0.36 0.33
Time × RF 0.00 90.57 −1.31 0.194 −0.01 0.00
Time × treatment 0.00 88.32 −1.40 0.164 −0.01 0.00
RF × treatment 0.07 92.26 0.21 0.831 −0.54 0.67
Time × treatment × RF 0.01 97.21 2.12 0.036 0.00 0.02
Table 4
Pre-post treatment effect sizes for patients with low and medium RF in step-down and outpatient treatment conditions. Calculations are based on LMM estimates,
and the between treatment effect sizes are based on the 6 year estimates.
Outcome
measure
Step-down Outpatient Between treatment
comparison
Baseline 6 years Pre-post
effect
size
Baseline 6 years Pre-post
effect
size
Between
group
effect
size
Treatment
with
largest
effect size
mean SD mean SD mean SD mean SD
Low RF GSI 1.86 0.53 1.39 0.57 0.86 1.78 0.50 1.06 0.54 1.38 0.58 Outpatient
CIP 1.97 0.36 1.63 1.98 0.82 1.75 0.32 0.97 0.43 2.07 0.43 Outpatient
GAF 46.1 2.7 55.1 4.5 2.44 46.5 3.7 69.6 7.2 4.03 2.52 Outpatient
WSAS 26.3 5.3 18.6 7.0 1.23 23.7 5.4 15.2 7.4 1.30 0.47 Outpatient
ISE 67.0 7.7 57.7 9.5 1.08 58.4 10.1 46.5 14.4 0.96 0.95 Step-down
Self-control 2.51 0.41 2.87 0.44 0.85 2.60 0.41 3.23 0.51 1.38 0.77 Outpatient
Identity 1.83 0.41 2.52 0.52 1.47 1.97 0.47 2.94 0.58 1.84 0.78 Outpatient
Relation 2.15 0.43 2.57 0.44 0.97 2.20 0.53 3.03 0.58 1.48 0.9 Outpatient
High RF GSI 1.59 0.45 0.70 0.48 1.92 1.45 0.57 1.15 0.62 0.51 0.8 Step-down
CIP 1.62 0.36 0.95 0.47 1.60 1.54 0.41 1.23 0.55 0.63 0.55 Step-down
GAF 47.3 2.9 69.7 6.3 4.59 47.7 3.0 65.8 7.5 3.16 0.57 Step-down
WSAS 22.4 5.2 10.5 6.8 1.98 20.5 6.3 12.7 8.5 1.05 0.29 Step-down
ISE 53.8 8.8 39.4 11.2 1.43 54.4 11.3 46.3 15.4 0.60 0.52 Step-down
Self-control 2.56 0.37 3.33 0.41 1.96 2.59 0.55 2.84 0.59 0.44 0.95 Step-down
Identity 2.30 0.34 3.42 0.38 3.11 2.31 0.56 2.83 0.63 0.87 1.13 Step-down
Relation 2.59 0.48 3.28 0.54 1.36 2.62 0.53 3.06 0.61 0.77 0.38 Step-down
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Fig. 2. Course of outcome variables for patients with low and medium RF in the step-down and outpatient treatment conditions, estimates from the LMM
analyses.(1) Global Severity Index, (2) Circumplex of interpersonal problems, (3) Global Assessment of Functioning, (4) Work and Social Adjustment Scale, (5)
Self-esteem, (6) Self-control, (7) Identity Integration, (8) Relation Capacity.
54 B.T. Antonsen et al. / Comprehensive Psychiatry 64 (2016) 46–58p = .02. As in the intention-to-treat analysis, patients with
medium RF achieved better clinical outcome in the step-down
treatment condition while patients with a low RF attained better
results when in the outpatient treatment condition. A total of 43
patients contributed to the complete case analysis: 25 in the
step-down program and 18 in the outpatient treatment. Of these
were 12 patients in the low RF group, and 31 patients in the
medium RF group.4. Discussion
First, the present study shows an association between RF
and a wide range of clinical variables in a sample of patientswith BPD and/or AvPD. Before entering study treatment,
patients in the low RF group reported higher levels of
symptomatic and interpersonal distress, more self-esteem
problems, lower psychosocial functioning, and lower
levels of personality functioning regarding identity and
relational functioning.
The associations between RF and intensity of symptom
distress and psychosocial impairment indicate that the
mentalization construct captures clinically relevant phenom-
ena. The cross-sectional and correlational nature of our
findings limits conclusions regarding the direction of these
associations and thereby causality. However, Chiesa and
Fonagy [19] found that RFwas a significant mediator between
childhood adversity and symptom distress, supporting that
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development of severe symptoms in patients with PD.
Moreover, we found statistically significant associations
between RF and the SIPP-118 personality functioning
domains Identity Integration and Relational Capacity, as
well as self-esteem and interpersonal problems, implying
that RF is indeed related to personality pathology in terms of
disturbances in self and self in relation to others. These
findings are in line with Fonagy et al.’s idea of mentalization
deficits as a core aspect of PDs [2,17]. A relation between
personality functioning and RF is also in accordance with the
findings of Fischer-Kern et al. [22], who reported in a sample
of BPD patients a significant association between RF and
personality organization. They performed their assessment
using the STIPO, which covers several domains of
personality functioning including identity consolidation
and quality of object relations. In addition, Müller et al.
[44] found a significant correlation between RF and
personality organization in a sample of patients with
depression or eating disorders. In that study, personality
organization was assessed by the structure axis (axis IV) of
the operation psychodynamic diagnostics (OPD) [58,59],
based on an OPD interview. Like the STIPO methodology,
the structure axis of OPD aims to cover a broad set of
personality domains such as self and object recognition,
regulation, communication, and attachment [58]. In a recent
report by Doering et al. [60], axis IV of the OPD was used as
a measure of the level of personality functioning, and PD
patients showed significantly worse results on axis IV
outcomes than patients without PD.
Although the present study shows a broad association
between RF and clinical variables we found no difference
between groups with low and medium RF in the Self-control
domain of SIPP-118. This was somewhat surprising since
the Self-control domain is meant to capture the characteristic
BPD problems of emotional hyperarousal and impulsivity,
the same BPD features that mentalizing capacity is thought
to buffer against. [14] One reason for the lack of an
association between Self-control and RF could be that RF
measured by AAI primarily captures mentalizing abilities
related to early attachment relationships, and is neither a
score of patients’ general mentalization abilities nor a score
that captures other specific deficits in mentalization [3,61].
This concern is also raised by Fonagy and Luyten [18], who
state that patients’mentalizing capacity is likely to be altered
in states of emotional arousal and that the AAI interview may
not capture more fluctuating mentalizing deficits in current
situations and relationships. Thus, it could be that future
research should address the question of more domain- or
context specific versions of RF. Symptom-specific RF
versions already exist for panic disorder [62] and obsessive–
compulsive disorder [63], and these studies indicate that a
patient’s symptom-specific RF is lower than a patient’s RF
as assessed by the AAI interview. On the other hand, moving
to more symptom- or context specific measures of RF may
reduce it’s value as a trans-diagnostic construct. It risk’sbecoming a more circumscribed construct and could thus
lose its ability to be compared across samples and studies.
Whether it is possible to balance or combine such different
perspectives in future developments of assessment of
mentalizing abilities should be a topic for further discussion
and research.
In the present sample there were a greater proportion of
patients with AvPD than BPD in the low RF group. This
finding indicates that mentalizing problems are not limited to
BPD but may be a feature of other types of personality
pathology as well. Whether AvPD is associated with even
more mentalizing difficulties than BPD is not clear.
Mentalizing deficits in patients with AvPD could reflect a
more general limited access to mental states and poor
emotional awareness [25,64], rather than context dependent
hyperarousal and impulsivity typical of BPD. Thus, related
to the discussion above, there is a possibility that AAI based
RF is not equally able to capture the particular mentalizing
problems in different PDs.
The second aim of this study was to investigate whether
RF is associated with long-term clinical course. In line with
the findings at 3-year follow-up [46], in the current study we
did not identify RF as a significant predictor of 6-year
outcome. Correspondingly, Taubner et al. [10] found that the
level of RF did not predict outcome in terms of change in
symptoms during long-term psychoanalytic treatment for
patients with chronic depression. On the other hand, Müller
et al. [44], investigating patients with depression or eating
disorders who received 3 months of inpatient treatment,
found that pretreatment RF level was significantly correlated
with improvement in overall mental condition. These studies
are difficult to compare with the current study and with each
other because of differences in diagnoses, treatments and
duration of the follow-up investigations. Clearly, more
studies are needed to determine the long-term impact of
pre-treatment mentalization capacity.
An important finding in the present study is that when
taking type of treatment into account, we found significant
moderator effects of RF. Patients with low RF had better
outcomes in the outpatient treatment condition compared to
the step-down program. This finding concurs with the results
from the 3-year follow-up [46]. The current results also
extend the findings of Gullestad et al. [46] by detecting
differences in symptomatic distress, interpersonal problems,
and personality functioning in addition to psychosocial
functioning. Moreover, a novel finding in this 6-year
follow-up was that the patients in the medium RF group
achieved better results in the step-down program than in the
outpatient treatment. Effect sizes estimated for comparison
of 6-year outcomes in the two treatment conditions were in
the large range for six of the eight outcome variables,
indicating strong clinical significance.
Although several factors may have caused the moderator
effects, one of the most obvious structural differences
between the treatment conditions was the use of group
psychotherapy in the step-down treatment. A possible
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the step-down treatment may therefore be that the group
psychotherapy was too demanding for patients with a low
capacity for understanding themselves and others. This may
also be the explanation why patients with low RF in fact
achieved greater results in the outpatient treatment than in
the step-down program. On the other hand, the group therapy
format might not have been as influential as the type of group
therapy offered in the present project. The group therapists in
the step-down treatment were trained in group analytic
therapy, a therapeutic style and approach that could be
suitable for patients with some capacity for making sense of
their own and others’ mental states but that may be too
unstructured for patients with low or absent mentalizing
capacity. In a study by Kvarstein et al. [65], clinical
outcomes for BPD patients in a psychodynamically oriented
treatment program resembling UPP’s step-down treatment
were compared with a mentalization-based treatment
program (MBT) in which group psychotherapy was
specifically structured. The results were clearly in favor of
the latter. That study did not, however, include measures of
mentalization capacity. An interesting issue for further
research is to what extent the more structured MBT group
therapy is beneficial for patients low in RF.
In contrast to patients with low RF, patients in the
medium RF group improved more on several clinical
variables when treated in the step-down program as
compared to the outpatient treatment. How can we
understand this finding? We may hypothesize that patients
with an RF level of at least 3 would presumably have a
greater capacity to engage in a therapeutic project involving
perception of and reflection on mental states and interper-
sonal issues. The complex group setting might then not be
overwhelming, and important therapeutic factors such as
therapeutic alliance and group cohesion [66] may evolve. If
the patient feels reasonably secure, the group may provide an
arena for social exposure and interpersonal learning. The
group format may thus challenge and stimulate mentalization
more than individual therapy alone. In our study, patients
with medium levels of RF may have been more capable of
learning from their own emotional experiences in interactions
with group members and how their own behavior could impact
others’ feelings. Moreover, when combined with individual
therapy, as was the case in the step-down condition, the patients
can receive guidance about understanding the group interactions
and further reflect on how the individual patients understand
both themselves and the other group members.
It is important to keep in mind that UPP is a study of
treatment formats rather than of specific psychotherapeutic
orientations and techniques. The treatments were not
manualized, and there was no registration of treatment
processes. Thus, interpretations of the moderator effects are
highly speculative. However, the results suggest that the
long-term outcome of intensive combined treatment may be
favorable for patients with a minimum of mentalizing
capacity. Patients with low RF, however, may benefit fromthe less intensive and more flexible outpatient individual
therapy format, which gives the therapist a better opportunity
to monitor and adjust to a patient’s ongoing or fluctuating
levels of mentalizing.
In contrast to most other studies on RF, we dichotomized
the RF scores into categories of low and medium RF, and
like Fonagy et al. [14], we set a cutoff at RF 3. Transcripts
rated below 3 on the RF scale will be characterized by very
restricted to complete absence of RF, e.g., the subjects give
concrete explanations and refer to physical or sociological,
rather than psychological, reasons for human behaviors. On
the other hand, in transcripts rated RF 3 or above, subjects
are usually capable of referring to mental state explanations,
although some may be rudimentary or cliché. Hence, our
study differentiates between patients with or without
mentalizing capacity and was not designed to reveal finer
potential differences between patients with, for example,
medium and high mentalizing capacity.
The strengths of the present study include its randomized
design and the long-term follow-up of long-term therapies
with a wide range of clinical outcomes. Additionally, the two
treatments were conducted in ordinary clinical settings, and
few severe cases with complicated comorbidity were
excluded, thus strengthening the study’s external validity.
The study includes patients with BPD and AvPD, which are
the two most commonly occurring PDs in clinical settings,
making the sample clinically relevant. However, investiga-
tion of possible differences in RF associated with PD
diagnoses, although a highly relevant research issue, was not
within the scope of the present study and would also be
limited because of the sample size. The present study did not
control for patients intelligence or other cognitive measures
potentially influencing treatment outcome. Another limita-
tion of this study was the relatively low number of
participants, making it prone to type II errors. Also, although
the response rate was acceptable, missing data and violation
of MAR assumptions could bias the results. On the other
hand, the complete case analyses support the validity of the
present findings.
In the outpatient treatment condition, the therapists treated
patients according to their own preferred method and practice.
Although this approach strengthened the ecological validity of
the study, the results could potentially have been different if
patients had received individual psychotherapeutic treatment in
accordance with more established specialized PD treatment.
Lastly, another limitation is that we did not take into account
treatments the patients may have received during the 6-year
follow-up period.5. Conclusions
The findings in this study indicate that RF is associated
with core aspects of personality pathology and captures
clinically relevant phenomena in adult patients with PDs.
Moreover, patients with different capacities for reflection
57B.T. Antonsen et al. / Comprehensive Psychiatry 64 (2016) 46–58may need different kinds of therapeutic approaches. The
present findings point towards several important issues for
future research. The clinical manifestations of varying levels
of RF suggest that mentalization may be an important target
in psychotherapies for patients with PDs. We need more
knowledge regarding to what degree mentalizing abilities
may develop as a result of treatment and how different
psychotherapies may contribute to improvement in RF.
Future studies should also investigate the clinical implica-
tions of such changes. Measuring RF on the basis of AAI is a
time-consuming method, and to stimulate research on these
topics, further methodological developments in RF assess-
ments should be encouraged.Acknowledgment
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